+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
TRUALT

TruAlt Bioenergy Share Price

 

 

TruAlt Bioenergy live price: ₹495.2. It opened at ₹499 vs previous close ₹489; intraday high/low: ₹505/₹488. The 50 DMA stands at ₹474.20.

TruAlt Bioenergy Performance

  • Today's Low
  • ₹488
  • Today's High
  • ₹505
  • 52 Week Low
  • ₹310
  • 52 Week High
  • ₹549
  • Open Price₹499
  • Previous Close₹489
  • Volume317,704
  • 50 DMA₹474.20
  • 100 DMA₹455.64
  • 200 DMA-

TruAlt Bioenergy Chart

Investment Returns

  • Over 1 Month + 10.71%
  • Over 3 Month + 26.79%
  • Over 6 Month + 20.9%
  • Over 1 Year -0.81%

Smart Investing Starts Here Start SIP with TruAlt Bioenergy for Steady Growth!

Invest Now

TruAlt Bioenergy Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 44.2
  • PEG Ratio
  • -1.3
  • Market Cap Cr
  • 4,247
  • P/B Ratio
  • 2.8
  • Average True Range
  • 22.32
  • EPS
  • 11.19
  • Dividend Yield
  • 0
  • MACD Signal
  • 10.39
  • RSI
  • 49.58
  • MFI
  • 63.94

Latest Stock News Updates

TruAlt gets 150 crore PM JI-VAN aid for sustainable aviation fuel project

The approval was granted by the Centre for High Technology (CHT) under the Ministry of Petroleum & Natural Gas (MoPNG), the company said

Q4FY26 & FY26 Result Announced for TruAlt Bioenergy Ltd.

Sugar company TruAlt Bioenergy announced Q4FY26 & FY26 results Consolidated Financial Highlights: Revenue from Operations: The consolidated revenue from operations for Q4FY26 stood at Rs 59,551.97 lakh, registering a decline of 16.50% QoQ compared to Rs 71,323.75 lakh in Q3FY26, and a drop of 34.34% YoY against Rs 90,698.87 lakh in Q4FY25. For the full year FY26, revenue stood at Rs 1,72,750.66 lakh, down by 9.45% YoY from Rs 1,90,772.40 lakh in FY25. Total Income: Total income for Q4FY26 was Rs 62,690.67 lakh, down by 14.22% QoQ (vs Rs 73,085.95 lakh in Q3FY26) and 31.91% YoY (vs Rs 92,067.83 lakh in Q4FY25). For FY26, total income was Rs 1,81,395.91 lakh, marking a 7.85% YoY decrease from Rs 1,96,852.78 lakh in FY25. Profit Before Tax (PBT): PBT for Q4FY26 came in at Rs 8,370.25 lakh, representing a decline of 6.67% QoQ (vs Rs 8,968.26 lakh in Q3FY26) and 24.52% YoY (vs Rs 11,089.78 lakh in Q4FY25). For FY26, PBT stood at Rs 12,995.47 lakh, down by 18.50% YoY compared to Rs 15,944.28 lakh in FY25. Profit After Tax (PAT): The net profit for Q4FY26 stood at Rs 6,094.97 lakh, falling 11.91% QoQ (vs Rs 6,918.95 lakh in Q3FY26) and 45.43% YoY (vs Rs 11,169.36 lakh in Q4FY25). For the full year FY26, PAT was Rs 9,686.98 lakh, a decline of 33.94% YoY against Rs 14,663.85 lakh in FY25. Total Comprehensive Income: The company posted a total comprehensive income of Rs 6,104.80 lakh in Q4FY26 (vs Rs 6,923.78 lakh in Q3FY26 and Rs 11,164.66 lakh in Q4FY25). For FY26, it stood at Rs 9,710.18 lakh, compared to Rs 14,664.25 lakh in FY25. Standalone Financial Highlights: Revenue from Operations: Standalone revenue for Q4FY26 was Rs 60,322.11 lakh, indicating a QoQ decrease of 14.19% (vs Rs 70,302.26 lakh in Q3FY26) and a YoY drop of 32.92% (vs Rs 89,927.45 lakh in Q4FY25). For FY26, revenue was Rs 1,70,465.34 lakh, down by 9.33% YoY from Rs 1,88,011.66 lakh in FY25. Total Income: Standalone total income in Q4FY26 came in at Rs 61,661.67 lakh, falling 14.45% QoQ (vs Rs 72,072.44 lakh in Q3FY26) and 32.46% YoY (vs Rs 91,292.32 lakh in Q4FY25). For FY26, total income was Rs 1,77,293.69 lakh, down by 8.64% YoY from Rs 1,94,070.60 lakh in FY25. Profit Before Tax (PBT): The standalone PBT was Rs 7,900.27 lakh in Q4FY26, dropping 7.94% QoQ (vs Rs 8,581.54 lakh in Q3FY26) and 27.61% YoY (vs Rs 10,913.60 lakh in Q4FY25). For FY26, PBT was Rs 10,947.48 lakh, down by 28.05% YoY from Rs 15,215.11 lakh in FY25. Profit After Tax (PAT): Standalone net profit for Q4FY26 was Rs 5,673.15 lakh, declining 14.07% QoQ (vs Rs 6,601.90 lakh in Q3FY26) and 48.53% YoY (vs Rs 11,022.81 lakh in Q4FY25). For FY26, PAT stood at Rs 8,083.00 lakh, representing a 42.52% YoY drop compared to Rs 14,061.53 lakh in FY25. Total Comprehensive Income: Standalone total comprehensive income for Q4FY26 was Rs 5,683.26 lakh. For FY26, it stood at Rs 8,026.20 lakh. Business Highlights: Segment-wise Performance: The Group's businesses are classified into two primary segments: Ethanol and other products: FY26 reported revenue of Rs 1,70,502.73 lakh with a segment result of Rs 59,462.80 lakh, compared to FY25 revenue of Rs 1,88,384.32 lakh and a segment result of Rs 60,978.14 lakh. Compressed Biogas: FY26 reported revenue of Rs 2,247.93 lakh with a segment result of Rs 1,842.20 lakh, compared to FY25 revenue of Rs 2,388.08 lakh and a segment result of Rs 2,023.21 lakh. Successful IPO: The Company's IPO was oversubscribed by 75.02 times. On September 30, 2025, the company allotted 1,51,20,967 equity shares of face value Rs 10 at a premium of Rs 486 per share, aggregating to Rs 734,87,89,962. Shares listed on the NSE and BSE on October 3, 2025. Capacity Enhancement (Dual-feed conversion): The company developed dual-feed capability (incorporating maize and rice alongside sugarcane syrup/molasses) to mitigate raw material dependency. Dual-feed capacities were installed at Unit 1 (November 2025), Unit 2 (February 2026), and Unit 4 (January 2026). Unit 5 remained non-operational pending Consent to Operate (CTO) receipts. Favorable High Court Order: The Karnataka High Court, via an order dated February 4, 2026, allowed a Writ Petition allowing a 90-day timeline extension to fulfill a shortfall of 1,56,292 kilolitres of ethanol to OMCs for ESY 2024–25 (valued at approximately Rs 1,075 crore). Joint Venture for CBG Plants: Following a JV agreement with Sumitomo Corporation on November 11, 2025, Sumitomo acquired a 49% equity interest (1,13,77,743 equity shares) in TruAlt Gas Private Limited on April 16, 2026, at Rs 30.90 per share. The JV plans to establish compressed biogas (CBG) plants at five identified locations. GAIL Stake Acquisition in Subsidiary: On March 18, 2026, GAIL (India) Limited acquired a 49% stake in subsidiary Leafiniti Bioenergy Private Limited via the allotment of 1,35,43,215 equity shares at Rs 10 each (aggregating Rs 13.54 crore). The Holding Company retains the balance 51% stake. Sustainable Aviation Fuel (SAF) Entry: On January 28, 2026, the company entered into an agreement with Honeywell to deploy its Ethanol-to-Jet (ETJ) process technology for an SAF production facility with an envisaged capacity of roughly 80,000 tonnes per annum. Auditor Appointments: The Board appointed M/s ZADN and Associates LLP as Internal Auditors and M/s R. Nanabhoy & Co. as Cost Auditors for FY27. Vijay Nirani, Managing Director, TruAlt Bioenergy, said: Warm greetings! I would like to thank our shareholders, partners and teams for their continued trust in TruAlt Bioenergy as we present our performance for Q4FY26. For decades, the world assumed energy would always remain available and secure. That illusion now stands broken. Geopolitical conflicts, volatile crude oil markets and fragile supply chains have exposed a dangerous reality that nations dependent on imported energy remain vulnerable to every global disruption. History has already shown how nations such as Brazil accelerated biofuels to insulate their economies from oil shocks, geopolitical volatility and external energy disruptions. Today, as geopolitical uncertainty continues to reshape the global order, the importance of indigenous biofuels has never been more critical. India has responded with strategic intent through its accelerated push toward higher ethanol blending, expansion of compressed biogas production and broader renewable energy ecosystems, recognising energy security as both an economic necessity and a strategic imperative. FY 2025–26 began with significant disruption across the ethanol industry. The Ethanol Supply Year 2025-26 (November to October) opened with notable changes in procurement and allocation patterns, with actual offtake remaining materially below both industry expectations and OMC requirements. Despite adequate raw material availability and fully operational capacities, several producers including us, witnessed sharp cuts in allocations, resulting in severe underutilisation of capacities across the sector. While overall ethanol demand for ESY 2025–26, including private OMCs, was estimated at nearly 1,300 to 1,400 crore litres, actual procurement remained lower by almost 200 crore litres. Historically, Karnataka supplied ethanol to deficit states; however, with surplus capacities now emerging within those regions, interstate supplies also witnessed restrictions. The deferred quantities are eventually expected to be absorbed and higher blending targets could drive incremental ethanol demand of nearly 350 to 400 crore litres in the coming months. For TruAlt Bioenergy, these broader industry developments coincided with one of the most defining phases in the Company’s journey, a year marked by significant opportunities, industry-wide disruptions and evolving geopolitical realities that increasingly reshaped the global energy landscape and intensified the strategic global spotlight on energy security and biofuels. The Company completed its first year as a listed entity during a period when India’s bioenergy sector continued to gain increasing national and global relevance amid volatile crude oil markets, supply chain disruptions and growing emphasis on indigenous energy alternatives. Simultaneously, TruAlt Bioenergy integrated approximately 1,300 KLPD of dual-feed infrastructure within its total installed ethanol capacity of 2,000 KLPD, strategically transitioning from a seasonal sugarcane-linked model to a near-continuous, multi-feedstock platform aimed at enhancing long-term feedstock flexibility, operational efficiency and production continuity. During this planned transition phase, certain contracted quantities could not be supplied and corresponding allocations remained unlifted. To protect its legitimate allocation position, the Company approached the Hon’ble Karnataka High Court and successfully secured judicial backing pertaining to the supply of approximately 15 crore litres. While execution timelines extended beyond the anticipated Q4 period following receipt of the order on 4th February 2026, the pending quantity represents an estimated revenue potential of nearly Rs 1,062 crore and is expected to contribute positively to the Company’s future growth trajectory and operational recovery in the coming periods. Result PDF

TruAlt Bioenergy's Q3 net drops 8% to 69.19 crore

TruAlt completed a key phase of operating consolidation in the ethanol segment during the quarter, with the planned capital expenditure for grain-based integration fully commissioned

TruAlt Bioenergy Financials

TruAlt Bioenergy Technicals

EMA & SMA

Current Price
₹495.20
+ 6.2 (1.27%)
pointer
  • Bearish Moving Average 7
  • Bullish Moving Average 7
  • 20 Day
  • ₹494.20
  • 50 Day
  • ₹474.20
  • 100 Day
  • ₹455.60
  • 200 Day
  • -

Resistance and Support

490.37 Pivot Speed
  • R3 507.53
  • R2 502.27
  • R1 495.63
  • S1 483.73
  • S2 478.47
  • S3 471.83

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

TruAlt Bioenergy is India’s largest ethanol producer by installed capacity and a diversified biofuels leader. Its portfolio spans ethanol, CBG, ENA, and organic manure, with upcoming ventures in 2G ethanol, sustainable aviation fuel, and green hydrogen for clean energy transition.

Trualt Bioenergy Ltd has an operating revenue of Rs. 1,727.51 Cr. on a trailing 12-month basis. An annual revenue de-growth of -8% needs improvement, Pre-tax margin of 8% is okay, ROE of 6% is fair but needs improvement. The company has a debt to equity of 65%, which is bit higher. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 13% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around -3% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 73 which is a FAIR score but needs to improve its earnings, a RS Rating of 69 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 21 indicates it belongs to a strong industry group of Energy-Alternative/Other and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

TruAlt Bioenergy Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-22 Audited Results
2026-02-03 Quarterly Results
2025-11-11 Quarterly Results
2025-10-19 Quarterly Results

TruAlt Bioenergy Shareholding Pattern

70.55%
6.7%
0.38%
0.66%
0%
13.5%
8.21%

TruAlt Bioenergy FAQs

TruAlt Bioenergy share price is ₹495 As on 19 June, 2026 | 13:30

The Market Cap of TruAlt Bioenergy is ₹4246.5 Cr As on 19 June, 2026 | 13:30

The P/E ratio of TruAlt Bioenergy is 44.2 As on 19 June, 2026 | 13:30

The PB ratio of TruAlt Bioenergy is 2.8 As on 19 June, 2026 | 13:30

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23